See All Slides - tctmd.com

Slides

Presentation TCT 2013

The SYNTAX Score Predicts Acute Kidney Injury After PCI for NSTEACS: Analysis from the ACUITY Trial

Presenter: Mahesh V. Madhavan

October 29, 2013

Presentation TCT 2013

Case Presentation and Topic Review: Treatment Considerations in a Symptomatic HCM Patient with Large Residual Gradient After Septal Ablation

Presenter: Srihari Naidu

October 29, 2013

Presentation TCT 2013

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

Presenter: Masato Nakamura

October 29, 2013

Presentation

Key Drivers in the Elective PCI Market

Presenter: Sunil Rao

October 29, 2013

Presentation TCT 2013

Long-Term Outcomes of Percutaneous Left Ventricular Pseudoaneurysm Closure

Presenter: Robert Kumar

October 29, 2013

Presentation TCT 2013

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Presenter: Bent Raungaard

October 29, 2013

Presentation TCT 2013

Case 2: Chronic Total Occulsion (Piedmont Heart Institute, Atlanta, GA)

Presenter: Julie Logan

October 29, 2013

Presentation TCT 2013

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Presenter: Stephan Windecker

October 29, 2013

Presentation TCT 2013

Repair vs. Replacement for Functional MR

Presenter: Robert Guyton

October 29, 2013

Presentation TCT 2013

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Presenter: Ulrich Jorde

October 29, 2013

Advertisement

Slides

The SYNTAX Score Predicts Acute Kidney Injury After PCI for NSTEACS: Analysis from the ACUITY Trial

Case Presentation and Topic Review: Treatment Considerations in a Symptomatic HCM Patient with Large Residual Gradient After Septal Ablation

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

Key Drivers in the Elective PCI Market

Long-Term Outcomes of Percutaneous Left Ventricular Pseudoaneurysm Closure

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Case 2: Chronic Total Occulsion (Piedmont Heart Institute, Atlanta, GA)

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Repair vs. Replacement for Functional MR

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content